National Jalma Institute of Leprosy And Other Mycobacterial Diseases
National Jalma Institute of Leprosy and Other Mycobacterial Diseases is a government research institute under India's ICMR in Agra, conducting specialized research and referral diagnostics across leprosy, tuberculosis, HIV/AIDS, and filariasis using BSL-3, DNA chip, and proteomics facilities.
- Company typePrivate
- Founded1976
- HeadquartersAgra, India
- Headcount51–100
- GTM typeB2B
- OfferingServices
What National Jalma Institute of Leprosy And Other Mycobacterial Diseases does
National Jalma Institute of Leprosy and Other Mycobacterial Diseases (NJIL&OMD) is a government research institute headquartered in Agra, Uttar Pradesh, operating under the Indian Council of Medical Research (ICMR), Department of Health Research, Ministry of Health & Family Welfare, Government of India. Originally established in 1966 as the India Centre of JALMA under the Tokyo-based Japanese Leprosy Mission for Asia, the institute was transferred to the Government of India on April 1, 1976 and renamed to its current designation in 2005 to reflect its broadened research mandate. The institute employs 67 personnel and concentrates 40% of its research effort on leprosy, 40% on tuberculosis and other mycobacteriosis, 10% on HIV/AIDS, and 10% on filariasis and related infections.
NJIL&OMD operates state-of-the-art laboratory facilities including a BSL-3 biosafety laboratory, a DNA Chip Laboratory, a Proteomics Laboratory, and electron microscopy units, along with departments spanning Biochemistry, Immunology, Microbiology & Molecular Biology, Pathology, Animal Experiments, Statistics, and Epidemiology. Its deliverable surface includes the proprietary LEPStr and HIVStr strain/genetic databases, comprehensive laboratory diagnostic services across seven divisions, referral diagnostic services for leprosy, tuberculosis, HIV/AIDS, and other mycobacterial infections, a six-month dissertation program for postgraduate researchers, and PhD programs conducted under the Academy of Scientific and Innovative Research (AcSIR). The institute also operates field programmes at Ghatampur alongside its Agra headquarters.
The institute's business model is non-commercial: it is fully funded through ICMR government allocations, with services (referral diagnostics, multi-centric study coordination, research training) provided without disclosed pricing or fee-based revenue. Its customer base consists of healthcare providers and research institutions requiring specialized diagnostic testing, ICMR and other government health bodies for national disease surveillance, and academic researchers and doctoral students pursuing advanced training. No private funding, external investment, or revenue-generating commercial activities are recorded, and pricing for any service is not publicly disclosed.
National Jalma Institute of Leprosy And Other Mycobacterial Diseases firmographics
Firmographics- Name
- National Jalma Institute of Leprosy And Other Mycobacterial Diseases
- Legal name
- National Jalma Institute for Leprosy & Other Mycobacterial Diseases
- Website
- https://jalma-icmr.org.in
- Company type
- Private
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- National Jalma Institute of Leprosy and Other Mycobacterial Diseases is a government research institute under India's ICMR in Agra, conducting specialized research and referral diagnostics across leprosy, tuberculosis, HIV/AIDS, and filariasis using BSL-3, DNA chip, and proteomics facilities.
- Ownership category
- akta.pro rank
National Jalma Institute of Leprosy And Other Mycobacterial Diseases industry classification
Industry- Product category
- Infectious Disease Research and Diagnostics
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Tuberculosis & Mycobacterial Diseases (HLAKAGAH)
- akta.pro secondary industries
- Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS) (HLAJABAC), Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
Keywords
Where National Jalma Institute of Leprosy And Other Mycobacterial Diseases is headquartered
LocationHeadquarters
- HQ city
- Agra
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
National Jalma Institute of Leprosy And Other Mycobacterial Diseases business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Distribution channels1 record
Marketing channels3 records
National Jalma Institute of Leprosy And Other Mycobacterial Diseases product offering
Product offeringCore offering
The National Jalma Institute of Leprosy and Other Mycobacterial Diseases (NJIL&OMD) is a government research institute under ICMR that conducts specialized research and provides referral-level laboratory diagnostic services in leprosy, tuberculosis and other mycobacterial diseases, HIV/AIDS, and filariasis. It operates across seven scientific departments (Biochemistry, Immunology, Microbiology & Molecular Biology, Electron Microscopy, Pathology, Animal Experiments, and Clinical Division), supports BSL-3, DNA chip, and Proteomics laboratory capabilities, maintains public genetic databases (LEPStr, HIVStr), and runs academic training including a Six Month Dissertation Program and AcSIR-affiliated PhD program.
Product overview
National Jalma Institute of Leprosy And Other Mycobacterial Diseases (NJIL&OMD) is a premier research institute under the Indian Council of Medical Research (ICMR). The institute operates as a unified research facility offering specialized databases (LEPStr and HIVStr), comprehensive laboratory diagnostic services across seven specialized divisions (Biochemistry, Immunology, Microbiology & Molecular Biology, Electron Microscopy, Pathology, Animal Experiments, and Clinical Division), academic training programs (Six Month Dissertation Program), and clinical referral services for leprosy, tuberculosis, HIV-AIDS, and other mycobacterial diseases. The institute focuses approximately 40% on leprosy research, 40% on tuberculosis and mycobacteriosis, 10% on HIV, and 10% on filariasis and related infections.
Differentiator
Problem solved
Functional benefit
Products and services
- LEPStr Database A specialized database for leprosy research maintained by ICMR-NJIL&OMD, containing genetic and strain information relevant to mycobacterial disease research. Hosted on the institute's website as a resource for researchers and academics.
- HIVStr Database A specialized database for HIV research maintained by ICMR-NJIL&OMD, containing genetic and strain information relevant to HIV-AIDS research. Hosted on the institute's website as a public-facing resource.
- Laboratory Diagnostic Services Comprehensive laboratory services across seven specialized units — Biochemistry, Immunology, Microbiology & Molecular Biology, Electron Microscopy, Pathology, Animal Experiments, and Clinical Division — provided to healthcare providers, researchers, and referring institutions for diagnosis of leprosy, tuberculosis, HIV/AIDS, and other mycobacterial diseases.
- Referral Diagnostic Services Diagnostic referral services for leprosy, tuberculosis, HIV/AIDS, and other mycobacterial infections, provided to hospitals, clinics, and public health programs through the institute's clinical division and modern hospital facilities.
- Six Month Dissertation Program Structured training program for students to conduct research projects at the institute, offering experience in pathogen handling (BSL-2 and BSL-3) and Microbiology and Molecular Biology methods. Students are admitted through notified application cycles.
- AcSIR PhD Program (Medical Research) Doctoral program in medical research affiliated with the Academy of Scientific and Innovative Research (AcSIR), with ICMR-NJIL&OMD functioning as a research center for PhD scholars. Offers advanced research training in leprosy, tuberculosis, HIV/AIDS, and other mycobacterial diseases.
Companies that use National Jalma Institute of Leprosy And Other Mycobacterial Diseases
Customer profileSegments3 records
Ideal customer profiles2 records
National Jalma Institute of Leprosy And Other Mycobacterial Diseases technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
National Jalma Institute of Leprosy And Other Mycobacterial Diseases partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and major.
- Government of India / Indian Council of Medical Research (ICMR)coreThe institute was officially handed over to the Government of India on April 1, 1976, and subsequently placed under the Indian Council of Medical Research. Functions under Department of Health Research.
- JALMA (Japanese Leprosy Mission for Asia)coreOriginally established as 'India Centre of JALMA' in 1966 and managed by this Tokyo-based voluntary organization. This international collaboration represents a significant example of humanitarian cooperation in leprosy research and treatment.
- AcSIR (Academy of Scientific and Innovative Research)majorCollaborative PhD program where the institute serves as a research center under AcSIR for medical research doctoral programs.
Scale indicators5 records
Recent moves8 records
Expansion highlights4 records
National Jalma Institute of Leprosy And Other Mycobacterial Diseases competitors and assessment
Company assessmentDirect peers
- Schieffelin Institute of Health Research and Leprosy Centre: Karigiri-based research centre focused on leprosy and mycobacterial diseases, with comparable diagnostic/referral services, field programmes, and training offerings for leprosy research similar to NJIL&OMD's mandate.
- Leprosy Mission Trust India: NGO running referral hospitals, field programmes, and research on leprosy across India - operating an analogous leprosy-centric diagnostic, research, and training model to NJIL&OMD's 40% leprosy portfolio.
- National AIDS Research Institute (NARI): ICMR institute in Pune dedicated to HIV/AIDS research and clinical trials, directly comparable as a sibling ICMR entity working on the same disease pillar (HIV) that consumes 10% of NJIL&OMD's focus.
- Central Leprosy Teaching and Research Institute (CLTRI): Chengalpattu-based government institute under the Ministry of Health focused on leprosy training and research, with closely overlapping diagnosis, training, and field-programme activities to NJIL&OMD.
- National Institute of Tuberculosis, Respiratory and Allied Diseases (NITRD): Delhi-based autonomous institute under the Ministry of Health specialising in TB, respiratory, and mycobacterial disease clinical care and research, serving as a comparable referral and tertiary research centre.
- National Institute for Research in Tuberculosis (NIRT): Sister ICMR institute headquartered in Chennai that is India's primary dedicated TB research centre, sharing the same parent (ICMR) and overlapping TB/mycobacterial research agenda with NJIL&OMD.
Emerging players
- Foundation for Innovative New Diagnostics (FIND): Geneva-based global non-profit focused on diagnostic innovation for TB and other poverty-related diseases; overlaps with NJIL&OMD in TB drug-resistance and reference diagnostics, though operating globally rather than as a domestic institute.
Broad incumbents
- National Institute of Cholera and Enteric Diseases (NICED): Kolkata-based ICMR institute covering enteric infections and diarrhoeal disease research, comparable as a sister ICMR entity with a similar government-funded research institute operating model though in a different disease area.
- Christian Medical College (CMC) Vellore: Private teaching hospital and research centre with active infectious disease, microbiology, and molecular epidemiology programmes, comparable in scale of laboratory diagnostics and academic training offerings.
- National Institute of Virology (NIV): Pune-based ICMR institute working on viral diagnostics and outbreak response with comparable BSL-3 laboratory infrastructure, sharing the same parent organisation (ICMR) and public-health reference-lab role.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
National Jalma Institute of Leprosy And Other Mycobacterial Diseases social profiles
Digital presenceNational Jalma Institute of Leprosy And Other Mycobacterial Diseases financial estimates
Financial estimateRevenue estimate
Valuation estimate
National Jalma Institute of Leprosy And Other Mycobacterial Diseases leadership team
Management profileNumber of profiles
Profiles2 records
National Jalma Institute of Leprosy And Other Mycobacterial Diseases funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
National Jalma Institute of Leprosy And Other Mycobacterial Diseases M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about National Jalma Institute of Leprosy And Other Mycobacterial Diseases
What does National Jalma Institute of Leprosy And Other Mycobacterial Diseases do?
The National Jalma Institute of Leprosy and Other Mycobacterial Diseases (NJIL&OMD) is a government research institute under ICMR that conducts specialized research and provides referral-level laboratory diagnostic services in leprosy, tuberculosis and other mycobacterial diseases, HIV/AIDS, and filariasis. It operates across seven scientific departments (Biochemistry, Immunology, Microbiology & Molecular Biology, Electron Microscopy, Pathology, Animal Experiments, and Clinical Division), supports BSL-3, DNA chip, and Proteomics laboratory capabilities, maintains public genetic databases (LEPStr, HIVStr), and runs academic training including a Six Month Dissertation Program and AcSIR-affiliated PhD program.
Is National Jalma Institute of Leprosy And Other Mycobacterial Diseases a public or private company?
National Jalma Institute of Leprosy And Other Mycobacterial Diseases is a private company. It is classified as state government owned and is currently operating.
When was National Jalma Institute of Leprosy And Other Mycobacterial Diseases founded?
National Jalma Institute of Leprosy And Other Mycobacterial Diseases was founded in 1976. It employs 51 to 100 people.
Where is National Jalma Institute of Leprosy And Other Mycobacterial Diseases based?
National Jalma Institute of Leprosy And Other Mycobacterial Diseases is headquartered in Agra, India, in the Asia region.
Who are National Jalma Institute of Leprosy And Other Mycobacterial Diseases's main competitors?
Direct peers on record are Schieffelin Institute of Health Research and Leprosy Centre, Leprosy Mission Trust India, National AIDS Research Institute (NARI), Central Leprosy Teaching and Research Institute (CLTRI), National Institute of Tuberculosis, Respiratory and Allied Diseases (NITRD) and National Institute for Research in Tuberculosis (NIRT). Foundation for Innovative New Diagnostics (FIND) is listed as an emerging player. Broad incumbents are National Institute of Cholera and Enteric Diseases (NICED), Christian Medical College (CMC) Vellore and National Institute of Virology (NIV).
Does National Jalma Institute of Leprosy And Other Mycobacterial Diseases have an API?
No public API is recorded for National Jalma Institute of Leprosy And Other Mycobacterial Diseases.
What industry is National Jalma Institute of Leprosy And Other Mycobacterial Diseases in?
National Jalma Institute of Leprosy And Other Mycobacterial Diseases's product category is Infectious Disease Research and Diagnostics. Its primary akta.pro industry code is HLAKAGAH, Tuberculosis & Mycobacterial Diseases, with a secondary code of HLAJAIAD, Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza). Its NAICS code is 621511 and its SIC code is 8071.